Thermo Fisher Scientific Expands Bioproduction Capacity in Greater Boston
Thermo Fisher Scientific Inc. (Massachusetts, USA) has opened a new biomanufacturing facility in Chelmsford, Massachusetts. The $160 million, 85,000-square-foot facility will help meet growing demand for the biologic materials needed to produce vaccines and breakthrough therapies for cancer and other diseases. This new site is part of Thermo Fisher’s $650 million multi-year investment to expand its bioprocessing production capabilities.
“This market continues to grow, and the world’s leading biopharmaceutical companies depend on our technologies, services, and expertise to help deliver life-changing therapies to patients,” said Jean Luo, VP and General Manager, Purification and Pharma Analytics, Thermo Fisher Scientific.
The technologies produced at the Chelmsford site are used in the purification process of developing biotherapeutics and vaccines. These products help save time and reduce costs so that new treatments can reach more patients faster.
“The Chelmsford site will help us provide our customers with the critical resin materials they need as they scale up production and bring new innovations to market,” continued Luo. “This ultimately helps ensure more patients get the treatments they need faster.”
When fully staffed, the Chelmsford site will employ up to 250 people and will be part of Thermo Fisher’s global bioprocessing supply network.
For more information, please visit: www.thermofisher.com
Best of the Week: Food Analysis, Chemical Migration in Plastic Bottles, STEM Researcher of the Year
December 20th 2024Top articles published this week include the launch of our “From Lab to Table” content series, a Q&A interview about using liquid chromatography–high-resolution mass spectrometry (LC–HRMS) to assess chemical hazards in plastic bottles, and a piece recognizing Brett Paull for being named Tasmanian STEM Researcher of the Year.
Using LC-MS/MS to Measure Testosterone in Dried Blood Spots
December 19th 2024Testosterone measurements are typically performed using serum or plasma, but this presents several logistical challenges, especially for sample collection, storage, and transport. In a recently published article, Yehudah Gruenstein of the University of Miami explored key insights gained from dried blood spot assay validation for testosterone measurement.
Determination of Pharmaceuticals by Capillary HPLC-MS/MS (Dec 2024)
December 19th 2024This application note demonstrates the use of a compact portable capillary liquid chromatograph, the Axcend Focus LC, coupled to an Agilent Ultivo triple quadrupole mass spectrometer for quantitative analysis of pharmaceutical drugs in model aqueous samples.
